In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...
Previously head of GSK’s consumer health division ... for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating ...
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...
Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...
It is also the first facility designed for the new GSK Production Systems (GPS), whereby it will deliver the concepts of zero accidents, zero defects and zero waste.During FY2020,the company spent ...
Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley believes her company can … ...
GSK, known for developing vaccines against infectious diseases like shingles and influenza, has also been actively advancing new vaccines, including the recently approved respiratory syncytial virus ...
There has been a decidedly mixed response after the Adelaide Crows confirmed the design of their new logo going forward. The AFL club’s new logo was first leaked back in September and didn’t ...
Nippon Signal Company, Limited (JP:6741) has released an update. Nippon Signal Co., Ltd. reported a significant increase in its financial performance for the six months ending September 30 ...
Would Donald J. Trump come to the aid of Mayor Eric Adams of New York, an embattled Democrat indicted on federal corruption charges? By Jan Ransom While other big state Democrats are reviving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback